Endovascular Correction of Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Evaluation of Influence of These Treatments on the Symptoms of Multiple Sclerosis
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Multiple Sclerosis
- Sponsor
- Euromedic Specialist Clinics, Poland
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Change in clinical symptoms of multiple sclerosis measured by Extended Disability Severity Score (EDSS), Multiple Sclerosis Impact Scale-29 (MSIS-29), Fatigue Severity Scale (FSS) and heat intolerance
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
The aim of this study is to assess the efficacy of endovascular treatment (balloon angioplasty and/or stenting) for the improvement of clinical symptoms in multiple sclerosis patients.
Detailed Description
The aim of this study is to assess the efficacy of endovascular treatment (balloon angioplasty and/or stenting) for the improvement of clinical symptoms in multiple sclerosis patients measured by Extended Disability Severity Score (EDSS), Multiple Sclerosis Impact Scale-29 (MSIS-29), Fatigue Severity Scale (FSS) and heat intolerance
Investigators
Marian Simka
PhD
Euromedic Specialist Clinics, Poland
Eligibility Criteria
Inclusion Criteria
- •patients with clinically defined multiple sclerosis
Exclusion Criteria
- •contraindication for endovascular procedure performed in local anesthesia
Outcomes
Primary Outcomes
Change in clinical symptoms of multiple sclerosis measured by Extended Disability Severity Score (EDSS), Multiple Sclerosis Impact Scale-29 (MSIS-29), Fatigue Severity Scale (FSS) and heat intolerance
Time Frame: 6 months after the procedure